Prosight Management as of Dec. 31, 2022
Portfolio Holdings for Prosight Management
Prosight Management holds 40 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Galapagos Nv Spon Adr (GLPG) | 11.3 | $21M | 465k | 44.38 | |
| Prothena Corp SHS (PRTA) | 10.8 | $20M | 330k | 60.25 | |
| Kezar Life Sciences (KZR) | 6.7 | $12M | 1.8M | 7.04 | |
| Meiragtx Holdings (MGTX) | 5.8 | $11M | 1.6M | 6.52 | |
| Albireo Pharma | 5.7 | $11M | 487k | 21.61 | |
| Horizon Therapeutics Pub L SHS | 5.6 | $10M | 90k | 113.80 | |
| Alkermes SHS (ALKS) | 4.9 | $8.9M | 342k | 26.13 | |
| Humana (HUM) | 4.8 | $8.8M | 17k | 512.19 | |
| Oric Pharmaceuticals (ORIC) | 3.8 | $7.0M | 1.2M | 5.89 | |
| Mirum Pharmaceuticals (MIRM) | 3.3 | $6.0M | 309k | 19.50 | |
| Aldeyra Therapeutics (ALDX) | 3.3 | $6.0M | 859k | 6.96 | |
| Trinet (TNET) | 2.9 | $5.3M | 78k | 67.80 | |
| Cue Biopharma (CUE) | 2.9 | $5.2M | 1.8M | 2.85 | |
| Shattuck Labs (STTK) | 2.7 | $4.9M | 2.1M | 2.30 | |
| Option Care Health Com New (OPCH) | 2.5 | $4.7M | 155k | 30.09 | |
| Quidel Corp (QDEL) | 2.3 | $4.3M | 50k | 85.67 | |
| Kalvista Pharmaceuticals (KALV) | 2.3 | $4.2M | 622k | 6.76 | |
| Health Catalyst (HCAT) | 2.0 | $3.7M | 348k | 10.63 | |
| Abcellera Biologics (ABCL) | 1.8 | $3.3M | 323k | 10.13 | |
| Graphite Bio | 1.7 | $3.0M | 917k | 3.32 | |
| UnitedHealth (UNH) | 1.4 | $2.7M | 5.0k | 530.18 | |
| Intellia Therapeutics (NTLA) | 1.4 | $2.5M | 72k | 34.89 | |
| Cardiovascular Systems | 1.1 | $2.0M | 146k | 13.62 | |
| Oak Street Health | 1.0 | $1.8M | 84k | 21.51 | |
| Adc Therapeutics Sa SHS (ADCT) | 1.0 | $1.8M | 463k | 3.84 | |
| Galapagos Nv Call Call Option | 1.0 | $1.8M | 40k | 44.38 | |
| Seagen Call Call Option | 0.8 | $1.5M | 12k | 128.51 | |
| Lifestance Health Group (LFST) | 0.8 | $1.4M | 289k | 4.94 | |
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $1.3M | 117k | 11.48 | |
| Cassava Sciences Put Put Option | 0.7 | $1.2M | 41k | 29.54 | |
| Morphic Hldg (MORF) | 0.6 | $1.1M | 43k | 26.75 | |
| Aziyo Biologics Cl A Com (ELUT) | 0.4 | $786k | 185k | 4.25 | |
| Biomea Fusion (BMEA) | 0.4 | $691k | 82k | 8.43 | |
| Bridgebio Pharma (BBIO) | 0.4 | $678k | 89k | 7.62 | |
| Rocket Pharmaceuticals (RCKT) | 0.3 | $630k | 32k | 19.57 | |
| Gossamer Bio (GOSS) | 0.3 | $575k | 265k | 2.17 | |
| Evolus (EOLS) | 0.3 | $499k | 66k | 7.51 | |
| Oncology Institu (TOI) | 0.2 | $455k | 276k | 1.65 | |
| Tenaya Therapeutics (TNYA) | 0.1 | $215k | 107k | 2.01 | |
| Personalis Ord (PSNL) | 0.1 | $116k | 59k | 1.98 |
